Edible and medicinal mushrooms (, , ) reduce endoplasmic reticulum stress and inflammation in adipose tissue of obese Wistar rats fed with a high fat plus saccharose diet

Obesity is an increasing global public health problem. A strategy to treat obesity is the use of functional foods. Edible and medicinal mushrooms contain diverse bioactive compounds showing important antihyperlipidemic, antioxidant, and prebiotic properties. We analysed the effects of adding (10%) o...

Full description

Saved in:
Bibliographic Details
Published inFood & function Vol. 14; no. 11; pp. 548 - 561
Main Authors González-Ibáñez, Laura, Meneses, María E, Sánchez-Tapia, Mónica, Pérez-Luna, Daniel, Torres, Nimbe, Torre-Villalvazo, Iván, Bonilla, Myrna, Petlacalco, Beatriz, Castillo, Ivan, López-Barradas, Adriana, Macías, Antonio, Tovar, Armando R, Martínez-Carrera, Daniel
Format Journal Article
LanguageEnglish
Published England Royal Society of Chemistry 06.06.2023
Subjects
Adiponectin
Adipose tissue
Animal models
Atorvastatin
Bioactive compounds
Biological activity
Body composition
Body fat
Body weight gain
Collagen
Diet
Endoplasmic reticulum
Fat-free body mass
Functional foods & nutraceuticals
Ganoderma lucidum
High fat diet
Hypertrophy
Inflammation
Insulin resistance
Lipids
Mushrooms
Natural products
Obesity
Parameters
Pleurotus ostreatus
Proteins
Public health
Tumor necrosis factor-α
Ustilago maydis
Online AccessGet full text

Cover

Abstract Obesity is an increasing global public health problem. A strategy to treat obesity is the use of functional foods. Edible and medicinal mushrooms contain diverse bioactive compounds showing important antihyperlipidemic, antioxidant, and prebiotic properties. We analysed the effects of adding (10%) of Pleurotus ostreatus ( Po , basidiomata), Ganoderma lucidum ( Gl , basidiomata), or Ustilago maydis ( Um , galls), milled, to a high fat plus saccharose diet (HFD + S) for 6 months in a model of obesity with Wistar rats. We assessed weight gain, body composition, lipid parameters, endoplasmic reticulum stress (proteins and inflammatory markers: BiP, XBP-1, JNK, p-JNK, TNF-α), and adiponectin in subcutaneous adipose tissue (SAT). The consumption of edible and medicinal mushrooms decreased weight gain (−17.2-30.1%) and fat mass (−23.7-43.1%), maintained fat-free mass, reduced levels of serum biochemical parameters (TC: −40.1-44.1%, TG: −37.7-51.6%, LDL-C: −64.5-71.1%), and prevented adipocyte hypertrophy (−30.9-36.9%) and collagen deposition (−70.9-73.7%) in SAT. Compared with the HFD + S group, mushroom consumption by Wistar rats significantly reduced the expression of proteins associated with endoplasmic reticulum stress and inflammation (BiP: −72.2-88.2%; XBP-1: −71.5-81.8%; JNK: −71.2-90.0%; p-JNK: −37.3-81.0%; TNF-α: −80.7-91.5%), whereas significantly increased adiponectin protein expression (246.4-654.2%) in SAT. These effects outperformed those obtained through the commercial lipid-lowering drug atorvastatin, contributing synergistically to prevent further obesity-related dysfunctions, such as insulin resistance derived from inflammation and ER stress in adipose tissue. Bioactive compounds from edible, functional and medicinal mushrooms represent new emerging therapies for obesity treatments using natural products. Edible and medicinal mushrooms reduce endoplasmic reticulum stress and inflammation in adipose tissue of obese Wistar rats fed with a high fat plus saccharose diet.
AbstractList Obesity is an increasing global public health problem. A strategy to treat obesity is the use of functional foods. Edible and medicinal mushrooms contain diverse bioactive compounds showing important antihyperlipidemic, antioxidant, and prebiotic properties. We analysed the effects of adding (10%) of Pleurotus ostreatus (Po, basidiomata), Ganoderma lucidum (Gl, basidiomata), or Ustilago maydis (Um, galls), milled, to a high fat plus saccharose diet (HFD + S) for 6 months in a model of obesity with Wistar rats. We assessed weight gain, body composition, lipid parameters, endoplasmic reticulum stress (proteins and inflammatory markers: BiP, XBP-1, JNK, p-JNK, TNF-α), and adiponectin in subcutaneous adipose tissue (SAT). The consumption of edible and medicinal mushrooms decreased weight gain (-17.2-30.1%) and fat mass (-23.7-43.1%), maintained fat-free mass, reduced levels of serum biochemical parameters (TC: -40.1-44.1%, TG: -37.7-51.6%, LDL-C: -64.5-71.1%), and prevented adipocyte hypertrophy (-30.9-36.9%) and collagen deposition (-70.9-73.7%) in SAT. Compared with the HFD + S group, mushroom consumption by Wistar rats significantly reduced the expression of proteins associated with endoplasmic reticulum stress and inflammation (BiP: -72.2-88.2%; XBP-1: -71.5-81.8%; JNK: -71.2-90.0%; p-JNK: -37.3-81.0%; TNF-α: -80.7-91.5%), whereas significantly increased adiponectin protein expression (246.4-654.2%) in SAT. These effects outperformed those obtained through the commercial lipid-lowering drug atorvastatin, contributing synergistically to prevent further obesity-related dysfunctions, such as insulin resistance derived from inflammation and ER stress in adipose tissue. Bioactive compounds from edible, functional and medicinal mushrooms represent new emerging therapies for obesity treatments using natural products.Obesity is an increasing global public health problem. A strategy to treat obesity is the use of functional foods. Edible and medicinal mushrooms contain diverse bioactive compounds showing important antihyperlipidemic, antioxidant, and prebiotic properties. We analysed the effects of adding (10%) of Pleurotus ostreatus (Po, basidiomata), Ganoderma lucidum (Gl, basidiomata), or Ustilago maydis (Um, galls), milled, to a high fat plus saccharose diet (HFD + S) for 6 months in a model of obesity with Wistar rats. We assessed weight gain, body composition, lipid parameters, endoplasmic reticulum stress (proteins and inflammatory markers: BiP, XBP-1, JNK, p-JNK, TNF-α), and adiponectin in subcutaneous adipose tissue (SAT). The consumption of edible and medicinal mushrooms decreased weight gain (-17.2-30.1%) and fat mass (-23.7-43.1%), maintained fat-free mass, reduced levels of serum biochemical parameters (TC: -40.1-44.1%, TG: -37.7-51.6%, LDL-C: -64.5-71.1%), and prevented adipocyte hypertrophy (-30.9-36.9%) and collagen deposition (-70.9-73.7%) in SAT. Compared with the HFD + S group, mushroom consumption by Wistar rats significantly reduced the expression of proteins associated with endoplasmic reticulum stress and inflammation (BiP: -72.2-88.2%; XBP-1: -71.5-81.8%; JNK: -71.2-90.0%; p-JNK: -37.3-81.0%; TNF-α: -80.7-91.5%), whereas significantly increased adiponectin protein expression (246.4-654.2%) in SAT. These effects outperformed those obtained through the commercial lipid-lowering drug atorvastatin, contributing synergistically to prevent further obesity-related dysfunctions, such as insulin resistance derived from inflammation and ER stress in adipose tissue. Bioactive compounds from edible, functional and medicinal mushrooms represent new emerging therapies for obesity treatments using natural products.
Obesity is an increasing global public health problem. A strategy to treat obesity is the use of functional foods. Edible and medicinal mushrooms contain diverse bioactive compounds showing important antihyperlipidemic, antioxidant, and prebiotic properties. We analysed the effects of adding (10%) of Pleurotus ostreatus (Po, basidiomata), Ganoderma lucidum (Gl, basidiomata), or Ustilago maydis (Um, galls), milled, to a high fat plus saccharose diet (HFD + S) for 6 months in a model of obesity with Wistar rats. We assessed weight gain, body composition, lipid parameters, endoplasmic reticulum stress (proteins and inflammatory markers: BiP, XBP-1, JNK, p-JNK, TNF-α), and adiponectin in subcutaneous adipose tissue (SAT). The consumption of edible and medicinal mushrooms decreased weight gain (−17.2–30.1%) and fat mass (−23.7–43.1%), maintained fat-free mass, reduced levels of serum biochemical parameters (TC: −40.1–44.1%, TG: −37.7–51.6%, LDL-C: −64.5–71.1%), and prevented adipocyte hypertrophy (−30.9–36.9%) and collagen deposition (−70.9–73.7%) in SAT. Compared with the HFD + S group, mushroom consumption by Wistar rats significantly reduced the expression of proteins associated with endoplasmic reticulum stress and inflammation (BiP: −72.2–88.2%; XBP-1: −71.5–81.8%; JNK: −71.2–90.0%; p-JNK: −37.3–81.0%; TNF-α: −80.7–91.5%), whereas significantly increased adiponectin protein expression (246.4–654.2%) in SAT. These effects outperformed those obtained through the commercial lipid-lowering drug atorvastatin, contributing synergistically to prevent further obesity-related dysfunctions, such as insulin resistance derived from inflammation and ER stress in adipose tissue. Bioactive compounds from edible, functional and medicinal mushrooms represent new emerging therapies for obesity treatments using natural products.
Obesity is an increasing global public health problem. A strategy to treat obesity is the use of functional foods. Edible and medicinal mushrooms contain diverse bioactive compounds showing important antihyperlipidemic, antioxidant, and prebiotic properties. We analysed the effects of adding (10%) of Pleurotus ostreatus ( Po , basidiomata), Ganoderma lucidum ( Gl , basidiomata), or Ustilago maydis ( Um , galls), milled, to a high fat plus saccharose diet (HFD + S) for 6 months in a model of obesity with Wistar rats. We assessed weight gain, body composition, lipid parameters, endoplasmic reticulum stress (proteins and inflammatory markers: BiP, XBP-1, JNK, p-JNK, TNF-α), and adiponectin in subcutaneous adipose tissue (SAT). The consumption of edible and medicinal mushrooms decreased weight gain (−17.2–30.1%) and fat mass (−23.7–43.1%), maintained fat-free mass, reduced levels of serum biochemical parameters (TC: −40.1–44.1%, TG: −37.7–51.6%, LDL-C: −64.5–71.1%), and prevented adipocyte hypertrophy (−30.9–36.9%) and collagen deposition (−70.9–73.7%) in SAT. Compared with the HFD + S group, mushroom consumption by Wistar rats significantly reduced the expression of proteins associated with endoplasmic reticulum stress and inflammation (BiP: −72.2–88.2%; XBP-1: −71.5–81.8%; JNK: −71.2–90.0%; p-JNK: −37.3–81.0%; TNF-α: −80.7–91.5%), whereas significantly increased adiponectin protein expression (246.4–654.2%) in SAT. These effects outperformed those obtained through the commercial lipid-lowering drug atorvastatin, contributing synergistically to prevent further obesity-related dysfunctions, such as insulin resistance derived from inflammation and ER stress in adipose tissue. Bioactive compounds from edible, functional and medicinal mushrooms represent new emerging therapies for obesity treatments using natural products.
Obesity is an increasing global public health problem. A strategy to treat obesity is the use of functional foods. Edible and medicinal mushrooms contain diverse bioactive compounds showing important antihyperlipidemic, antioxidant, and prebiotic properties. We analysed the effects of adding (10%) of Pleurotus ostreatus ( Po , basidiomata), Ganoderma lucidum ( Gl , basidiomata), or Ustilago maydis ( Um , galls), milled, to a high fat plus saccharose diet (HFD + S) for 6 months in a model of obesity with Wistar rats. We assessed weight gain, body composition, lipid parameters, endoplasmic reticulum stress (proteins and inflammatory markers: BiP, XBP-1, JNK, p-JNK, TNF-α), and adiponectin in subcutaneous adipose tissue (SAT). The consumption of edible and medicinal mushrooms decreased weight gain (−17.2-30.1%) and fat mass (−23.7-43.1%), maintained fat-free mass, reduced levels of serum biochemical parameters (TC: −40.1-44.1%, TG: −37.7-51.6%, LDL-C: −64.5-71.1%), and prevented adipocyte hypertrophy (−30.9-36.9%) and collagen deposition (−70.9-73.7%) in SAT. Compared with the HFD + S group, mushroom consumption by Wistar rats significantly reduced the expression of proteins associated with endoplasmic reticulum stress and inflammation (BiP: −72.2-88.2%; XBP-1: −71.5-81.8%; JNK: −71.2-90.0%; p-JNK: −37.3-81.0%; TNF-α: −80.7-91.5%), whereas significantly increased adiponectin protein expression (246.4-654.2%) in SAT. These effects outperformed those obtained through the commercial lipid-lowering drug atorvastatin, contributing synergistically to prevent further obesity-related dysfunctions, such as insulin resistance derived from inflammation and ER stress in adipose tissue. Bioactive compounds from edible, functional and medicinal mushrooms represent new emerging therapies for obesity treatments using natural products. Edible and medicinal mushrooms reduce endoplasmic reticulum stress and inflammation in adipose tissue of obese Wistar rats fed with a high fat plus saccharose diet.
Obesity is an increasing global public health problem. A strategy to treat obesity is the use of functional foods. Edible and medicinal mushrooms contain diverse bioactive compounds showing important antihyperlipidemic, antioxidant, and prebiotic properties. We analysed the effects of adding (10%) of ( , basidiomata), ( , basidiomata), or ( , galls), milled, to a high fat plus saccharose diet (HFD + S) for 6 months in a model of obesity with Wistar rats. We assessed weight gain, body composition, lipid parameters, endoplasmic reticulum stress (proteins and inflammatory markers: BiP, XBP-1, JNK, p-JNK, TNF-α), and adiponectin in subcutaneous adipose tissue (SAT). The consumption of edible and medicinal mushrooms decreased weight gain (-17.2-30.1%) and fat mass (-23.7-43.1%), maintained fat-free mass, reduced levels of serum biochemical parameters (TC: -40.1-44.1%, TG: -37.7-51.6%, LDL-C: -64.5-71.1%), and prevented adipocyte hypertrophy (-30.9-36.9%) and collagen deposition (-70.9-73.7%) in SAT. Compared with the HFD + S group, mushroom consumption by Wistar rats significantly reduced the expression of proteins associated with endoplasmic reticulum stress and inflammation (BiP: -72.2-88.2%; XBP-1: -71.5-81.8%; JNK: -71.2-90.0%; p-JNK: -37.3-81.0%; TNF-α: -80.7-91.5%), whereas significantly increased adiponectin protein expression (246.4-654.2%) in SAT. These effects outperformed those obtained through the commercial lipid-lowering drug atorvastatin, contributing synergistically to prevent further obesity-related dysfunctions, such as insulin resistance derived from inflammation and ER stress in adipose tissue. Bioactive compounds from edible, functional and medicinal mushrooms represent new emerging therapies for obesity treatments using natural products.
Author Bonilla, Myrna
Meneses, María E
Martínez-Carrera, Daniel
Pérez-Luna, Daniel
Tovar, Armando R
Petlacalco, Beatriz
Macías, Antonio
Sánchez-Tapia, Mónica
González-Ibáñez, Laura
Torre-Villalvazo, Iván
Castillo, Ivan
Torres, Nimbe
López-Barradas, Adriana
AuthorAffiliation Funcionales y Medicinales (CB-HCFM)
Centro de Biotecnología de Hongos Comestibles
Departamento de Fisiología de la Nutrición
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMNSZ)
CONACYT-Colegio de Postgraduados (CP)
Campus Puebla
Colegio de Postgraduados (CP)
AuthorAffiliation_xml – sequence: 0
  name: Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán (INCMNSZ)
– sequence: 0
  name: Funcionales y Medicinales (CB-HCFM)
– sequence: 0
  name: CONACYT-Colegio de Postgraduados (CP)
– sequence: 0
  name: Centro de Biotecnología de Hongos Comestibles
– sequence: 0
  name: Colegio de Postgraduados (CP)
– sequence: 0
  name: Departamento de Fisiología de la Nutrición
– sequence: 0
  name: Campus Puebla
Author_xml – sequence: 1
  givenname: Laura
  surname: González-Ibáñez
  fullname: González-Ibáñez, Laura
– sequence: 2
  givenname: María E
  surname: Meneses
  fullname: Meneses, María E
– sequence: 3
  givenname: Mónica
  surname: Sánchez-Tapia
  fullname: Sánchez-Tapia, Mónica
– sequence: 4
  givenname: Daniel
  surname: Pérez-Luna
  fullname: Pérez-Luna, Daniel
– sequence: 5
  givenname: Nimbe
  surname: Torres
  fullname: Torres, Nimbe
– sequence: 6
  givenname: Iván
  surname: Torre-Villalvazo
  fullname: Torre-Villalvazo, Iván
– sequence: 7
  givenname: Myrna
  surname: Bonilla
  fullname: Bonilla, Myrna
– sequence: 8
  givenname: Beatriz
  surname: Petlacalco
  fullname: Petlacalco, Beatriz
– sequence: 9
  givenname: Ivan
  surname: Castillo
  fullname: Castillo, Ivan
– sequence: 10
  givenname: Adriana
  surname: López-Barradas
  fullname: López-Barradas, Adriana
– sequence: 11
  givenname: Antonio
  surname: Macías
  fullname: Macías, Antonio
– sequence: 12
  givenname: Armando R
  surname: Tovar
  fullname: Tovar, Armando R
– sequence: 13
  givenname: Daniel
  surname: Martínez-Carrera
  fullname: Martínez-Carrera, Daniel
BackLink https://www.ncbi.nlm.nih.gov/pubmed/37161495$$D View this record in MEDLINE/PubMed
BookMark eNptks1rFTEUxYNUbK3duFcuuKnSp_mYryzl2apQ6EbR3XAnyTgpM5Nnbgbpv9S_0rz32grFVXLD7xy45-Q5O5jD7Bh7Kfh7wZX-YFUfOOeNNk_YkeSFXFUl_3lwfy90dchOiK4zk3Hd6OYZO1S1qEShyyN2e259NzrA2cLkrDd-xhGmhYYYwkRwegZn8Bais4tx4GYbNiPS5E1-St4s4zIBpeiIdhZ-7kecJkw-zHkAtH4TyEHyRIuD0EPoXJ5_eEoYIWIi6J2FPz4NgDD4XwP0mGAzLgSExgwYt3rrXXrBnvY4kju5O4_Z94vzb-svq8urz1_XHy9XRqk6rWTneC8sl8rIXncNWik4arS11AXWzhpZa6FsWfCmqhC1retOO6uEKbkxVh2z073vJobfi6PUTp6MG0ecXViolY0QWjWVLjP65hF6HZaYE9xSUlZFzVWRqdd31NLljNtN9BPGm_a-hQy82wMmL0vR9Q-I4O225faTurjatbzOMH8EG592gaeIfvy_5NVeEsk8WP_7OOoviwC0Qw
CitedBy_id crossref_primary_10_1016_j_fbio_2024_104768
crossref_primary_10_1002_mnfr_202400501
crossref_primary_10_1016_j_fbio_2023_103352
crossref_primary_10_1039_D3FO04166B
crossref_primary_10_1002_jobm_202400127
crossref_primary_10_26416_Diet_3_3_2023_8759
crossref_primary_10_3390_nu17010160
crossref_primary_10_3390_su162310666
Cites_doi 10.4014/jmb.1606.06049
10.1016/j.funbio.2019.04.003
10.1089/dia.2013.0208
10.1111/ijfs.13712
10.1016/j.scr.2016.07.002
10.1309/LM6T8D1LKQXVNCAC
10.1093/ecam/neh107
10.1038/90984
10.1093/jn/127.5.838S
10.1016/j.cca.2007.01.026
10.1016/j.jff.2010.11.004
10.1016/j.tifs.2016.09.006
10.4077/CJP.2014.BAC245
10.1038/s41574-019-0176-8
10.3390/nu13010038
10.1016/j.cell.2010.02.034
10.3390/ijms21176030
10.1038/nrendo.2015.114
10.1016/j.ijbiomac.2019.01.164
10.1038/oby.2009.471
10.1111/dom.13143
10.3390/ijms21041219
10.1371/journal.pone.0159631
10.4489/MYCO.2009.37.1.037
10.1007/s11130-016-0552-7
10.1016/j.jff.2019.04.042
10.1007/978-3-319-48382-5_7
10.5740/jaoacint.15-0289
10.1194/jlr.D023788
10.3109/08923973.2012.710635
10.1126/science.271.5249.665
10.1038/srep27486
10.1016/j.arcmed.2015.05.010
10.1002/jcb.26794
10.1080/08905439309549858
10.1161/ATVBAHA.107.160663
10.1126/science.1103160
10.1046/j.1440-1681.2003.03857.x
10.1038/sj.ijo.0802854
10.2174/1381612824666181001154242
10.1038/ncomms8489
ContentType Journal Article
Copyright Copyright Royal Society of Chemistry 2023
Copyright_xml – notice: Copyright Royal Society of Chemistry 2023
DBID AAYXX
CITATION
NPM
7T5
7T7
7TO
7U7
8FD
C1K
FR3
H94
P64
7X8
DOI 10.1039/d3fo00089c
DatabaseName CrossRef
PubMed
Immunology Abstracts
Industrial and Applied Microbiology Abstracts (Microbiology A)
Oncogenes and Growth Factors Abstracts
Toxicology Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
Biotechnology and BioEngineering Abstracts
MEDLINE - Academic
DatabaseTitle CrossRef
PubMed
Oncogenes and Growth Factors Abstracts
Technology Research Database
Toxicology Abstracts
AIDS and Cancer Research Abstracts
Immunology Abstracts
Engineering Research Database
Industrial and Applied Microbiology Abstracts (Microbiology A)
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
Oncogenes and Growth Factors Abstracts
CrossRef

PubMed
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Diet & Clinical Nutrition
Public Health
EISSN 2042-650X
EndPage 561
ExternalDocumentID 37161495
10_1039_D3FO00089C
d3fo00089c
Genre Journal Article
GroupedDBID ---
-JG
0-7
0R~
4.4
53G
705
7~J
AAEMU
AAHBH
AAIWI
AAJAE
AANOJ
AARTK
AAWGC
AAXHV
ABASK
ABDVN
ABEMK
ABJNI
ABPDG
ABRYZ
ABXOH
ACGFS
ACLDK
ACPRK
ADMRA
ADSRN
AEFDR
AENEX
AENGV
AESAV
AETIL
AFLYV
AFOGI
AFRAH
AFVBQ
AGEGJ
AGRSR
AGSTE
AHGCF
AKBGW
ALMA_UNASSIGNED_HOLDINGS
ANUXI
APEMP
ASKNT
AUDPV
AZFZN
BLAPV
BSQNT
C6K
EBS
ECGLT
EE0
EF-
GGIMP
H13
HZ~
H~N
J3I
O-G
O9-
P2P
RAOCF
RCNCU
RNS
RPMJG
RRC
RSCEA
RVUXY
SKF
SKH
SKJ
SKM
SKR
SKZ
SLC
SLF
AAYXX
AFRZK
AKMSF
CITATION
NPM
7T5
7T7
7TO
7U7
8FD
C1K
FR3
H94
P64
7X8
ID FETCH-LOGICAL-c337t-2be0f1d023c2f9b8ad210a9ad7294a7edc27913d540866aa9d77b9ed31c50ccd3
ISSN 2042-6496
2042-650X
IngestDate Fri Jul 11 05:36:42 EDT 2025
Mon Jun 30 11:57:33 EDT 2025
Thu Apr 03 07:07:17 EDT 2025
Tue Jul 01 03:02:55 EDT 2025
Thu Apr 24 22:53:39 EDT 2025
Tue Dec 17 20:58:25 EST 2024
IsPeerReviewed true
IsScholarly true
Issue 11
Language English
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c337t-2be0f1d023c2f9b8ad210a9ad7294a7edc27913d540866aa9d77b9ed31c50ccd3
Notes https://doi.org/10.1039/d3fo00089c
Electronic supplementary information (ESI) available. See DOI
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ORCID 0000-0002-1741-0984
0000-0001-7412-1153
0000-0002-7689-7024
0000-0003-3878-1802
PMID 37161495
PQID 2822647034
PQPubID 2047526
PageCount 14
ParticipantIDs rsc_primary_d3fo00089c
pubmed_primary_37161495
crossref_primary_10_1039_D3FO00089C
crossref_citationtrail_10_1039_D3FO00089C
proquest_miscellaneous_2811938695
proquest_journals_2822647034
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2023-06-06
PublicationDateYYYYMMDD 2023-06-06
PublicationDate_xml – month: 06
  year: 2023
  text: 2023-06-06
  day: 06
PublicationDecade 2020
PublicationPlace England
PublicationPlace_xml – name: England
– name: Cambridge
PublicationTitle Food & function
PublicationTitleAlternate Food Funct
PublicationYear 2023
Publisher Royal Society of Chemistry
Publisher_xml – name: Royal Society of Chemistry
References Mccleary (D3FO00089C/cit25/1) 2016; 99
Romero-Córdoba (D3FO00089C/cit13/1) 2020; 13
González (D3FO00089C/cit20/1) 2022
Dong (D3FO00089C/cit45/1) 2019; 129
Chen (D3FO00089C/cit38/1) 2016; 6
Huang (D3FO00089C/cit34/1) 2014; 57
Hossain (D3FO00089C/cit10/1) 2003; 30
Martínez-Carrera (D3FO00089C/cit22/1) 2022
Bowling (D3FO00089C/cit29/1) 2010; 41
Abe (D3FO00089C/cit46/1) 2008; 28
Castañeda de León (D3FO00089C/cit19/1) 2019; 6
Kang (D3FO00089C/cit18/1) 2016; 26
Hotamisligil (D3FO00089C/cit8/1) 1996; 271
Galarraga (D3FO00089C/cit31/1) 2012; 53
Torre-Villalvazo (D3FO00089C/cit4/1) 2018; 119
Valverde (D3FO00089C/cit21/1) 1993; 7
Yamauchi (D3FO00089C/cit44/1) 2001; 7
Holmes (D3FO00089C/cit33/1) 2015; 11
Freckmann (D3FO00089C/cit30/1) 2014; 2
Meneses (D3FO00089C/cit12/1) 2016; 11
Adebayo (D3FO00089C/cit26/1) 2018; 5
Blüher (D3FO00089C/cit1/1) 2019; 15
Schneider (D3FO00089C/cit11/1) 2011; 3
Martínez-Carrera (D3FO00089C/cit23/1) 2016
Pincu (D3FO00089C/cit32/1) 2016; 17
Hotamisligil (D3FO00089C/cit6/1) 2010; 140
AOAC (D3FO00089C/cit24/1) 2000
Caspard (D3FO00089C/cit3/1) 2018; 20
Ozcan (D3FO00089C/cit7/1) 2004; 306
DeBari (D3FO00089C/cit39/1) 2020; 17
Alam (D3FO00089C/cit16/1) 2009; 37
Lelliott (D3FO00089C/cit2/1) 2004; 28
Reeves (D3FO00089C/cit27/1) 1997; 127
Vamanu (D3FO00089C/cit40/1) 2018; 24
Patel (D3FO00089C/cit36/1) 2016; 57
Chang (D3FO00089C/cit15/1) 2015; 6
El Khoury (D3FO00089C/cit35/1) 2012; 2012
Choi (D3FO00089C/cit42/1) 2020; 21
Ravi (D3FO00089C/cit17/1) 2013; 35
Nixon (D3FO00089C/cit28/1) 2010; 8
He (D3FO00089C/cit37/1) 2019; 57
Torres (D3FO00089C/cit9/1) 2015; 46
Carobbio (D3FO00089C/cit5/1) 2017; 960
Calvo (D3FO00089C/cit41/1) 2016; 71
Ouchi (D3FO00089C/cit43/1) 2007; 380
Lindequist (D3FO00089C/cit14/1) 2005; 2
References_xml – issn: 2022
  publication-title: Efecto del consumo de hongos comestibles, funcionales y medicinales en un modelo de obesidad inducido por dieta: estrategia para mejorar el estado nutricional de las comunidades de San Miguel Tianguistenco y Santiago Coltzingo, Puebla, Colegio de Postgraduados, Programa en Estrategias para el Desarrollo Agrícola Regional
  doi: González
– issn: 2000
  publication-title: Official Methods of Analysis of the Association of Official Analytical Chemistry
  doi: AOAC
– issn: 2016
  publication-title: Ciencia, Tecnología e Innovación en el Sistema Agroalimentario de México
  doi: Martínez-Carrera Ramírez Juárez
– issn: 2022
  publication-title: Los Hongos Comestibles, Funcionales y Medicinales: Aportación a la Dieta, la Salud, la Cultura, al Ambiente, y al Sistema Agroalimentario de México
  doi: Martínez-Carrera Mayett Moreno Maimone Celorio
– volume: 26
  start-page: 1836
  year: 2016
  ident: D3FO00089C/cit18/1
  publication-title: J. Microbiol. Biotechnol.
  doi: 10.4014/jmb.1606.06049
– volume: 6
  start-page: 481
  year: 2019
  ident: D3FO00089C/cit19/1
  publication-title: Fungal Biol.
  doi: 10.1016/j.funbio.2019.04.003
– volume: 2
  start-page: 113
  year: 2014
  ident: D3FO00089C/cit30/1
  publication-title: Diabetes Technol. Ther.
  doi: 10.1089/dia.2013.0208
– volume: 5
  start-page: 1316
  year: 2018
  ident: D3FO00089C/cit26/1
  publication-title: Int. J. Food Sci. Technol.
  doi: 10.1111/ijfs.13712
– volume: 17
  start-page: 181
  year: 2016
  ident: D3FO00089C/cit32/1
  publication-title: Stem Cell Res.
  doi: 10.1016/j.scr.2016.07.002
– volume: 41
  start-page: 398
  year: 2010
  ident: D3FO00089C/cit29/1
  publication-title: Lab. Med.
  doi: 10.1309/LM6T8D1LKQXVNCAC
– volume: 2
  start-page: 285
  year: 2005
  ident: D3FO00089C/cit14/1
  publication-title: Evid. Based Complement. Alternat. Med.
  doi: 10.1093/ecam/neh107
– volume: 7
  start-page: 941
  year: 2001
  ident: D3FO00089C/cit44/1
  publication-title: Nat. Med.
  doi: 10.1038/90984
– volume: 127
  start-page: 838S
  year: 1997
  ident: D3FO00089C/cit27/1
  publication-title: J. Nutr.
  doi: 10.1093/jn/127.5.838S
– volume: 380
  start-page: 24
  year: 2007
  ident: D3FO00089C/cit43/1
  publication-title: Clin. Chim. Acta
  doi: 10.1016/j.cca.2007.01.026
– volume: 3
  start-page: 17
  year: 2011
  ident: D3FO00089C/cit11/1
  publication-title: J. Funct. Foods
  doi: 10.1016/j.jff.2010.11.004
– volume: 57
  start-page: 93
  year: 2016
  ident: D3FO00089C/cit36/1
  publication-title: Trends Food Sci. Technol.
  doi: 10.1016/j.tifs.2016.09.006
– volume-title: Official Methods of Analysis of the Association of Official Analytical Chemistry
  year: 2000
  ident: D3FO00089C/cit24/1
– volume: 57
  start-page: 198
  year: 2014
  ident: D3FO00089C/cit34/1
  publication-title: Chin. J. Physiol.
  doi: 10.4077/CJP.2014.BAC245
– volume: 15
  start-page: 288
  year: 2019
  ident: D3FO00089C/cit1/1
  publication-title: Nat. Rev. Endocrinol.
  doi: 10.1038/s41574-019-0176-8
– volume: 13
  start-page: 38
  year: 2020
  ident: D3FO00089C/cit13/1
  publication-title: Nutrients
  doi: 10.3390/nu13010038
– volume: 140
  start-page: 900
  year: 2010
  ident: D3FO00089C/cit6/1
  publication-title: Cell
  doi: 10.1016/j.cell.2010.02.034
– volume: 17
  start-page: 6030
  year: 2020
  ident: D3FO00089C/cit39/1
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms21176030
– volume: 11
  start-page: 504
  year: 2015
  ident: D3FO00089C/cit33/1
  publication-title: Nat. Rev. Endocrinol.
  doi: 10.1038/nrendo.2015.114
– volume: 129
  start-page: 316
  year: 2019
  ident: D3FO00089C/cit45/1
  publication-title: Int. J. Biol. Macromol.
  doi: 10.1016/j.ijbiomac.2019.01.164
– volume: 8
  start-page: 1652
  year: 2010
  ident: D3FO00089C/cit28/1
  publication-title: Obesity
  doi: 10.1038/oby.2009.471
– volume: 20
  start-page: 667
  year: 2018
  ident: D3FO00089C/cit3/1
  publication-title: Diabetes, Obes. Metab.
  doi: 10.1111/dom.13143
– volume: 21
  start-page: 1219
  year: 2020
  ident: D3FO00089C/cit42/1
  publication-title: Int. J. Mol. Sci.
  doi: 10.3390/ijms21041219
– volume-title: Ciencia, Tecnología e Innovación en el Sistema Agroalimentario de México
  year: 2016
  ident: D3FO00089C/cit23/1
– volume: 11
  start-page: e0159631
  year: 2016
  ident: D3FO00089C/cit12/1
  publication-title: PLoS One
  doi: 10.1371/journal.pone.0159631
– volume: 37
  start-page: 37
  year: 2009
  ident: D3FO00089C/cit16/1
  publication-title: Mycobiology
  doi: 10.4489/MYCO.2009.37.1.037
– volume: 71
  start-page: 245
  year: 2016
  ident: D3FO00089C/cit41/1
  publication-title: Plant Foods Hum. Nutr.
  doi: 10.1007/s11130-016-0552-7
– volume-title: Los Hongos Comestibles, Funcionales y Medicinales: Aportación a la Dieta, la Salud, la Cultura, al Ambiente, y al Sistema Agroalimentario de México
  year: 2022
  ident: D3FO00089C/cit22/1
– volume: 57
  start-page: 488
  year: 2019
  ident: D3FO00089C/cit37/1
  publication-title: J. Funct. Foods
  doi: 10.1016/j.jff.2019.04.042
– volume: 960
  start-page: 161
  year: 2017
  ident: D3FO00089C/cit5/1
  publication-title: Adv. Exp. Med. Biol.
  doi: 10.1007/978-3-319-48382-5_7
– volume: 99
  start-page: 364
  year: 2016
  ident: D3FO00089C/cit25/1
  publication-title: J. AOAC Int.
  doi: 10.5740/jaoacint.15-0289
– volume: 53
  start-page: 2791
  year: 2012
  ident: D3FO00089C/cit31/1
  publication-title: J. Lipid Res.
  doi: 10.1194/jlr.D023788
– volume: 35
  start-page: 101
  year: 2013
  ident: D3FO00089C/cit17/1
  publication-title: Immunopharmacol. Immunotoxicol.
  doi: 10.3109/08923973.2012.710635
– volume: 271
  start-page: 665
  year: 1996
  ident: D3FO00089C/cit8/1
  publication-title: Science
  doi: 10.1126/science.271.5249.665
– volume: 2012
  start-page: 851362
  year: 2012
  ident: D3FO00089C/cit35/1
  publication-title: J. Nutr. Metab.
– volume: 6
  start-page: 27486
  year: 2016
  ident: D3FO00089C/cit38/1
  publication-title: Sci. Rep.
  doi: 10.1038/srep27486
– volume: 46
  start-page: 408
  year: 2015
  ident: D3FO00089C/cit9/1
  publication-title: Arch. Med. Res.
  doi: 10.1016/j.arcmed.2015.05.010
– volume: 119
  start-page: 5970
  year: 2018
  ident: D3FO00089C/cit4/1
  publication-title: J. Cell. Biochem.
  doi: 10.1002/jcb.26794
– volume: 7
  start-page: 207
  year: 1993
  ident: D3FO00089C/cit21/1
  publication-title: Food Biotechnol.
  doi: 10.1080/08905439309549858
– volume: 28
  start-page: 871
  year: 2008
  ident: D3FO00089C/cit46/1
  publication-title: Arterioscler. Thromb. Vasc. Biol.
  doi: 10.1161/ATVBAHA.107.160663
– volume: 306
  start-page: 457
  year: 2004
  ident: D3FO00089C/cit7/1
  publication-title: Science
  doi: 10.1126/science.1103160
– volume: 30
  start-page: 470
  year: 2003
  ident: D3FO00089C/cit10/1
  publication-title: Clin. Exp. Pharmacol. Physiol.
  doi: 10.1046/j.1440-1681.2003.03857.x
– volume: 28
  start-page: S22
  issue: Suppl 4
  year: 2004
  ident: D3FO00089C/cit2/1
  publication-title: Int. J. Obes. Relat. Metab. Disord.
  doi: 10.1038/sj.ijo.0802854
– volume: 24
  start-page: 4144
  year: 2018
  ident: D3FO00089C/cit40/1
  publication-title: Curr. Pharm. Des.
  doi: 10.2174/1381612824666181001154242
– volume: 6
  start-page: 7489
  year: 2015
  ident: D3FO00089C/cit15/1
  publication-title: Nat. Commun.
  doi: 10.1038/ncomms8489
– volume-title: Efecto del consumo de hongos comestibles, funcionales y medicinales en un modelo de obesidad inducido por dieta: estrategia para mejorar el estado nutricional de las comunidades de San Miguel Tianguistenco y Santiago Coltzingo, Puebla, Colegio de Postgraduados, Programa en Estrategias para el Desarrollo Agrícola Regional
  year: 2022
  ident: D3FO00089C/cit20/1
SSID ssj0000399898
Score 2.3706007
Snippet Obesity is an increasing global public health problem. A strategy to treat obesity is the use of functional foods. Edible and medicinal mushrooms contain...
SourceID proquest
pubmed
crossref
rsc
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 548
SubjectTerms Adiponectin
Adipose tissue
Animal models
Atorvastatin
Bioactive compounds
Biological activity
Body composition
Body fat
Body weight gain
Collagen
Diet
Endoplasmic reticulum
Fat-free body mass
Functional foods & nutraceuticals
Ganoderma lucidum
High fat diet
Hypertrophy
Inflammation
Insulin resistance
Lipids
Mushrooms
Natural products
Obesity
Parameters
Pleurotus ostreatus
Proteins
Public health
Tumor necrosis factor-α
Ustilago maydis
Title Edible and medicinal mushrooms (, , ) reduce endoplasmic reticulum stress and inflammation in adipose tissue of obese Wistar rats fed with a high fat plus saccharose diet
URI https://www.ncbi.nlm.nih.gov/pubmed/37161495
https://www.proquest.com/docview/2822647034
https://www.proquest.com/docview/2811938695
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3db9MwEMCtfUhoL4ivQWFDh0CIKQSSOE2ax32Pj45JbFrfKsd2RKU0qdrkgf63_CfcxUmaaUMCXqLUseNK94t9Z9-dGXsTBrHnaE0hylLafqK4PRBxYotQovKd4IQoKd55eB6cXfmfR_3R2vpux2upLOIPcnlnXMn_SBXLUK4UJfsPkm1figV4j_LFK0oYr38l42M1ocAnWvuu98gpFqRc_CB1uFpOtS5Syr5RlAsrX1RO5SWVH1pX-Gmn5IMxFT_VxJSdioxORpsKKy3lRJVTi9YM5pTcVVs6U_kMVe1plfO5MMuGTaiJSeGUIF0mEpJWUYSazMgZvqhES0ppHmv8fU0a69xC8hZW0ji_C4vyJluJKKxZin9xISTFg1F7NdE39g9OKA8zAUtTcteN4DTPltW-v5vqpf0pNvd0PXDNOjkFgbfT0JBGeTNIDoVxGDgSq8CM76Z5hlAv7UsxM07Fw-p1POt4OF0YX4M5Vvtamgg7E7ffXVDxeOX4VafjrgZej0KWUHMd3Zgl_O7X4HbG_L5jcoXemowcTrlcFU9y0rQi2a2EIM2mFZYcLVYyU1cTcusm2TxaZ5seWkHeBtvc_3Jwet0uImIPdP5nk3aXRx9XvW2xe037mzrXLUMK1ap5c9xNpVZdPmD3a3sI9g3cD9mazh6x3hHKHN5CnbQ2hfPmzIjH7JeBHhA5aKGHFnp4By3y0CIP76EBHgzwWNLiDjXusAcGdujADi3sYGCveu7Cjj-ghh0M7JAnUMEOBnYg2AFhB4IdBBDsgLADwQ4r2IFgf8KuTo4vD8_s-pwSW3IeFrYXaydxFaIkvSSKB0J5riMiodBw9UWolfTCyOUKjaNBEAgRqTCMI624K_uOlIpvs40sz_QzBkGklJCujuUg8dEyGUg_SXg_4H5MWbScHttrJDmWdRJ_OksmHVfOJDwaH_GTbxUAhz32uq07M6lr7qy10wAxroe2xZh8ywMflQG_x161j3Hiod1Ekem8pDouGn-DIOr32FMDUttNA16PbSNZbfEKzud_bPKCba0-yh22UcxLvYt6fxG_rOn_DfOlBtg
linkProvider Royal Society of Chemistry
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Edible+and+medicinal+mushrooms+%28+Pleurotus+ostreatus+%2C+Ustilago+maydis+%2C+Ganoderma+lucidum+%29+reduce+endoplasmic+reticulum+stress+and+inflammation+in+adipose+tissue+of+obese+Wistar+rats+fed+with+a+high+fat+plus+saccharose+diet&rft.jtitle=Food+%26+function&rft.au=Gonz%C3%A1lez-Ib%C3%A1%C3%B1ez%2C+Laura&rft.au=Meneses%2C+Mar%C3%ADa+E&rft.au=S%C3%A1nchez-Tapia%2C+M%C3%B3nica&rft.au=P%C3%A9rez-Luna%2C+Daniel&rft.date=2023-06-06&rft.eissn=2042-650X&rft.volume=14&rft.issue=11&rft.spage=5048&rft_id=info:doi/10.1039%2Fd3fo00089c&rft_id=info%3Apmid%2F37161495&rft.externalDocID=37161495
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2042-6496&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2042-6496&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2042-6496&client=summon